首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Nuclear medicine and biology

缩写:NUCL MED BIOL

ISSN:0969-8051

e-ISSN:1872-9614

IF/分区:3.0/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1632
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Tomoteru Yamasaki,Yiding Zhang,Wakana Mori et al. Tomoteru Yamasaki et al.
Purpose: Translocator protein 18 kDa (TSPO) is a biomarker for neuroinflammation, and [18F]FEDAC was developed as a clinically usable radioligand for its imaging. Here, quantitative PET analyses of [18F]FEDAC in the brain...
Romain Fouinneteau,Nicolas Galland,Cécile Perrio et al. Romain Fouinneteau et al.
Astatine-211 is more than ever a serious candidate radionuclide to achieve success of targeted alpha therapy of cancers in the close future. However, several challenges remain to be overcome in order to guarantee the translation of 211At-la...
Diksha,Sarah C Donnelly,Mojmir Suchy et al. Diksha et al.
Purpose: Our bodies host a diverse and complex community of bacteria, known as the microbiota, which play a crucial role in overall wellness. The gut microbiota perform essential functions, such as food fermentation, path...
Angel Moldes-Anaya,Lorenzo Ragazzi,Torgil R Vanberg et al. Angel Moldes-Anaya et al.
Background: Emotional experiences modulate behavior by influencing the central and peripheral nervous systems, playing a crucial role in the pathophysiology of neuropsychiatric disorders. This study investigates the neura...
Hye Yeon Seo,Minseok Suh,Nadeem Ahmed Lodhi et al. Hye Yeon Seo et al.
Background: Prostate-specific membrane antigen (PSMA) is a promising target for imaging and theranostics in prostate cancer (PCa). Current PSMA tracers face limitations due to short half-lives and logistics. We developed ...
Yani Berckmans,Roxanne Wouters,Zeljka Raskovic-Lovre et al. Yani Berckmans et al.
Background: Targeted alpha therapy (TAT) is recognized as a promising approach for eradicating tumor micro-metastases, owing to its high linear energy transfer. These micro-metastases are often associated with elevated re...
Circe D van der Heide,Roisin McMorrow,Felipe Gama-Franceschi et al. Circe D van der Heide et al.
Background: Targeted radionuclide therapy (TRT) directed at fibroblast activation protein (FAP), highly expressed on cancer-associated fibroblasts (CAFs), is a promising approach for treating stroma-rich tumors such as pa...
Hiroaki Echigo,Masayuki Munekane,Takeshi Fuchigami et al. Hiroaki Echigo et al.
Introduction: Glioblastoma, the most aggressive and malignant glioma type, remains challenging to treat, necessitating novel therapeutic strategies. Building on our previous development of an 211At-labeled RGD peptide, Ga...
Mutsuho Murata,Kento Kannaka,Souta Tatsuta et al. Mutsuho Murata et al.
Purpose: Astatine-211 (211At) is one of the most promising α-particle-emitting radionuclides used for targeted-alpha therapy. Benzene derivatives are currently commonly used as 211At-labeling moieties for preparing 211At...
Nadia Audouin,Héloïse Dufour,Aurélien Vidal et al. Nadia Audouin et al.
Introduction: this study investigates the production of Lead-203 (203Pb) using a deuteron beam and demonstrates its application with DOTATATE for diagnostic imaging of neuroendocrine tumours (NETs) thanks to its γ-ray em...